Other languages CalciMedica, Inc.

Equities

CALC

US38942Q2021

End-of-day quote Nasdaq Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
5.38 ^USD	-0.37%		-1.82%	+88.11%

13/05	CalciMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24/04	Calcimedica Inc. Announces Last Patient Enrolled in Phase 2B Carpo Trial of Auxora? in Acute Pancreatitis	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CalciMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Calcimedica Inc. Announces Last Patient Enrolled in Phase 2B Carpo Trial of Auxora? in Acute Pancreatitis	24/04
Top Premarket Decliners	01/04
CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
CalciMedica Inc. Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International Acute Kidney Injury At the 29th International Aki & CRRT Conference	13/03
CalciMedica Gets FDA Nod for Phase 2 Trial of Acute Kidney Injury With Respiratory Failure Treatment	14/02
Calcimedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora? for the Treatment of Severe Acute Kidney Injury	13/02
Calcimedica Insider Bought Shares Worth $2,515,080, According to a Recent SEC Filing	26/01
CalciMedica Secures $55 Million Funding Deal With Investors; Shares Gain	22/01
CalciMedica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Top Premarket Decliners	07/11
CalciMedica Inc. Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition	02/11
CalciMedica Files $100 Million Mixed Shelf	14/23/14
CalciMedica Inc. Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis	09/23/09
Top Premarket Gainers	27/23/27
CalciMedicaAnnounces Executive Changes	23/23/23
Graybug Vision, Inc. will Change its Ticker to CALC from GRAY	21/23/21
Graybug Vision Renames as CalciMedica	21/23/21
CalciMedica, Inc. completed the acquisition of Graybug Vision, Inc. from a group of shareholders in a reverse merger transaction.	20/23/20
Graybug Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	09/23/09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CalciMedica, Inc.

Equities

CALC

US38942Q2021

Other languages

Filters